We are live on ! Find out more
SR

Summer Road Portfolio holdings

AUM $161M
1-Year Est. Return 27.24%
This Fund
S&P 500
This Quarter Est. Return
+7.67%
1 Year Est. Return
+27.24%
3 Year Est. Return
+129.62%
5 Year Est. Return
-16.44%
10 Year Est. Return
+274.48%
AUM
$34.9M
AUM Growth
+$10.8M
Cap. Flow
+$11.3M
Cap. Flow %
32.49%
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
CORV
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
+$11.2M
2
OCUL icon
Ocular Therapeutix
OCUL
+$80.2K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 74.85%
2 Consumer Discretionary 25.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OCUL icon
1
Ocular Therapeutix
OCUL
$2.58B
$15.1M 43.34%
3,804,788
+19,938
+0.5% +$80.2K
CORV
2
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$11M 31.51%
+3,475,000
New +$11.2M
SKIS
3
DELISTED
Peak Resorts, Inc.
SKIS
$8.77M 25.15%
1,926,500
– –

Similar funds

SFCM
Savoir Faire Capital Management Norwalk, Connecticut $161M AUM 3.8% 1-Year Est. Return
LWM
Lighthouse Wealth Management Ashland, Ohio $161M AUM 19.46% 1-Year Est. Return
MWM
Mascagni Wealth Management Clinton, Mississippi $161M AUM 26.58% 1-Year Est. Return
MCM
MidAtlantic Capital Management Richmond, Virginia $161M AUM 18.73% 1-Year Est. Return
BFS
Burr Financial Services Pleasant Hill, California $161M AUM 80.86% 1-Year Est. Return
MMCM
Murphy & Mullick Capital Management Smithtown, New York $161M AUM 39.43% 1-Year Est. Return
MWA
Merkkuri Wealth Advisors Hicksville, New York $161M AUM 19.9% 1-Year Est. Return
BWM
Bosman Wealth Management Redlands, California $161M AUM 115.22% 1-Year Est. Return

Summer Road's Q1 2019 Portfolio in Review

As of Q1 2019, Summer Road held 3 positions worth $34.9M, up 45% from $24.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Summer Road deployed $11.3M of net new capital in Q1 2019, opening 1 new position and adding to 1 existing holding. Its largest new stake was Correvio Pharma Corp. Ordinary Shares (Canada): 3,475,000 shares worth $11M.

By sector, the portfolio is most concentrated in Healthcare at 75% of assets, up from 63% a quarter earlier, followed by Consumer Discretionary.

  • Summer Road's largest Q1 2019 buy was Correvio Pharma Corp. Ordinary Shares (Canada): 3,475,000 shares worth $11M.
  • Summer Road added most to Ocular Therapeutix in Q1 2019, an estimated $80.2K increase.
  • Summer Road's ten largest holdings make up 100% of its $34.9M portfolio in Q1 2019.
  • Summer Road opened 1 new position and closed 0 in Q1 2019.
  • Summer Road's portfolio value rose 45% quarter-over-quarter to $34.9M.

Based on Summer Road's 13F filing for Q1 2019, filed 15 May 2019.